AMA issues governance framework for clinical AI agents
The American Medical Association's new framework sets four questions to guide safe use of autonomous AI in patient care.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Bemotrizinol: First New U.S. Sunscreen Chemical in 25 Years
The FDA-approved chemical bemotrizinol offers broad-spectrum protection with minimal skin absorption and no white streaks, though its environmental impact remains uncertain.
Lobbyists and trade groups jostle to shape state rules for medical AI
A closed-door workgroup backed by the Federation of State Medical Boards is drafting guidance that could become state law for AI in clinical care.
New mRNA Flu Shot Hard to Find in First Season
Moderna's newly approved mRNA flu vaccine is available at only a limited number of locations this season, and experts say patients may need to search for it.
Healthcare Legal Roundup: HIV Drug Scheme, COVID Test Fraud, and Abuse Cases
A weekly roundup of court cases shows healthcare providers and patients involved in fraud, abuse, and violence.
Hospital Stewardship Moves to Proactive, Tech-Enabled Models
A sponsored webinar highlights how real-time surveillance and closed-loop tools are helping pharmacists focus on high-risk patients and manage costs.
Medicare Open Enrollment Brings 2027 Drug Cost Changes
New Part D caps, negotiated drug prices, and a one-time Part B rebate define the 2027 Medicare season.
Hospital Workers Turn to Social Media for Humor and Grievances
A MedPage Today roundup shows clinicians using social media to mock night shift fears, complain about fax-based prior authorization, and share small practical wins.
SFDI Imaging Shows Promise for Assessing Scleroderma Skin Fibrosis
A noninvasive visible-light imaging method matched standard clinical scoring and biopsy results in scleroderma patients, pointing to a new way to monitor skin disease.
MIT president warns of 'serious drought' in research pipeline amid federal cuts
University leaders argue that shifting federal research money toward industry and national priorities could starve the curiosity-driven science that produces breakthroughs like CRISPR and optogenetics.
Centene launches gold card program to waive prior authorizations
Centene becomes the latest insurer to exempt high-performing providers from prior authorization requirements, responding to state and federal pressure for reform.
Former FDA leaders: DOGE cuts set agency back years
Three ex-FDA commissioners say mass layoffs destroyed institutional knowledge and urge the next leader to rebuild and protect the workforce.
Teen Anxiety Affects 17% but Many Go Untreated
New survey data and expert commentary highlight the scale of adolescent anxiety and the debate over its causes.
Whoop enters Medicare pilot with outcomes-based chronic care plan
Whoop becomes one of the first consumer wearable makers in Medicare's ACCESS pilot, betting on outcome-based payments for older patients.
One in Six Patients Report Disrespectful Language in Medical Records
A nationally weighted survey finds that disrespectful language in medical records is not rare, and most patients believe it could lead to worse health outcomes.
CGM Cuts HbA1c in Type 2 Diabetes Without Insulin
A randomized primary-care trial found continuous glucose monitors improved glucose control in non-insulin-treated type 2 diabetes.
Trump administration delays rule on imported medicines by 90 days
The 90-day delay gives critics more time to fight a rule that could cut off access to cheaper drugs from Canada and overseas.
After RJ Mitte's Suicide, a Call to Rethink Men's Mental Health
A psychologist reflects on the actor's death by suicide to highlight how masculine norms and hidden distress put young men at risk.